Manager × security

BVF INC/IL MLTX holdings history

Who else holds this security? →

MOONLAKE IMMUNOTHERAPEUTICS · CUSIP 61559X104 · CIK 1056807

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Log in to see them.
Citable facts

As of Sep 30, 2026, BVF INC/IL reported 16.00M MLTX (shares), valued at $187.22M, or 6.16% of its reported non-derivative portfolio. Filed Nov 16, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
6.16%
Shares
16.00M
16,001,284
Reported value
$187.22M
USD

Shares unchanged; reported value decreased 39.91%, and weight changed -1.81 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 20266.16%16,001,284SEC filing ↗Filed Nov 16, 2026
Q2 20267.97%16,001,284SEC filing ↗Filed Aug 14, 2026
Q1 20269.50%16,001,284SEC filing ↗Filed May 15, 2026
Q4 20258.76%19,751,284SEC filing ↗Filed Feb 17, 2026
Q3 20255.74%19,751,284SEC filing ↗Filed Nov 14, 2025
Q2 202533.31%19,751,284SEC filing ↗Filed Aug 14, 2025
Q1 202531.45%19,751,284SEC filing ↗Filed May 15, 2025
Q4 202436.25%19,751,284SEC filing ↗Filed Feb 14, 2025
Q3 202432.08%21,751,284SEC filing ↗Filed Nov 14, 2024
Q2 202426.81%21,751,284SEC filing ↗Filed Aug 14, 2024
Q1 202430.04%21,751,284SEC filing ↗Filed May 15, 2024
Q4 202332.87%21,751,284SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 202332.87%21,751,284$1.31BThe prior quarter is outside the free window. Log in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 202430.04%21,751,284$1.09BShares unchanged; reported value decreased 16.82%, and weight changed -2.83 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 202426.81%21,751,284$956.40MShares unchanged; reported value decreased 12.46%, and weight changed -3.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 202432.08%21,751,284$1.10BShares unchanged; reported value increased 14.67%, and weight changed +5.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 202436.25%19,751,284$1.07BShares decreased 9.19%; reported value decreased 2.48%, and weight changed +4.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 202531.45%19,751,284$771.68MShares unchanged; reported value decreased 27.85%, and weight changed -4.80 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 202533.31%19,751,284$932.26MShares unchanged; reported value increased 20.81%, and weight changed +1.86 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20255.74%19,751,284$141.62MShares unchanged; reported value decreased 84.81%, and weight changed -27.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20258.76%19,751,284$260.32MShares unchanged; reported value increased 83.82%, and weight changed +3.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20269.50%16,001,284$298.26MShares decreased 18.99%; reported value increased 14.58%, and weight changed +0.74 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20267.97%16,001,284$311.54MShares unchanged; reported value increased 4.45%, and weight changed -1.53 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Q3 20266.16%16,001,284$187.22MShares unchanged; reported value decreased 39.91%, and weight changed -1.81 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 16, 2026
BVF INC/IL · MOONLAKE IMMUNOTHERAPEUTICS

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"1056807","quarter":"2026Q3","cusip":"61559X104"}

akkru_institutional_holdings
{"action":"history","cik":"1056807","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.